KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

LifeMD (LFMD) Gross Margin (2016 - 2025)

LifeMD's Gross Margin history spans 14 years, with the latest figure at 40.22% for Q4 2025.

  • For Q4 2025, Gross Margin rose 6419.0% year-over-year to 40.22%; the TTM value through Dec 2025 reached 29.95%, down 5609.0%, while the annual FY2025 figure was 85.72%, 43.0% down from the prior year.
  • Gross Margin reached 40.22% in Q4 2025 per LFMD's latest filing, down from 87.69% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 90.59% in Q3 2024 to a low of 23.97% in Q4 2024.
  • Average Gross Margin over 5 years is 69.17%, with a median of 84.88% recorded in 2022.
  • Peak YoY movement for Gross Margin: plummeted -11203bps in 2024, then skyrocketed 6419bps in 2025.
  • A 5-year view of Gross Margin shows it stood at 79.69% in 2021, then increased by 7bps to 85.53% in 2022, then increased by 3bps to 88.06% in 2023, then crashed by -127bps to 23.97% in 2024, then soared by 268bps to 40.22% in 2025.
  • Per Business Quant, the three most recent readings for LFMD's Gross Margin are 40.22% (Q4 2025), 87.69% (Q3 2025), and 0.93% (Q2 2025).